Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 686505, 16 pages
http://dx.doi.org/10.1155/2014/686505
Research Article

Network Analysis of Neurodegenerative Disease Highlights a Role of Toll-Like Receptor Signaling

1The Microsoft Research, University of Trento Centre for Computational Systems Biology (COSBI), Piazza Manifattura 1, 38068 Rovereto, Italy
2Department of Mathematics, University of Trento, Via Sommarive, 14-38123 Povo, Italy

Received 5 September 2013; Revised 20 November 2013; Accepted 30 November 2013; Published 16 January 2014

Academic Editor: Stavros J. Hamodrakas

Copyright © 2014 Thanh-Phuong Nguyen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Przedborski, M. Vila, and V. Jackson-Lewis, “Neurodegeneration: what is it and where are we?” Journal of Clinical Investigation, vol. 111, no. 1, pp. 3–10, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A.-L. Barabási, N. Gulbahce, and J. Loscalzo, “Network medicine: a network-based approach to human disease,” Nature Reviews Genetics, vol. 12, no. 1, pp. 56–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Ideker and R. Sharan, “Protein networks in disease,” Genome Research, vol. 18, no. 4, pp. 644–652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Oti, B. Snel, M. A. Huynen, and H. G. Brunner, “Predicting disease genes using protein-protein interactions,” Journal of Medical Genetics, vol. 43, no. 8, pp. 691–698, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. G. Kann, “Protein interactions and disease: computational approaches to uncover the etiology of diseases,” Briefings in Bioinformatics, vol. 8, no. 5, pp. 333–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Schuster-Böckler and A. Bateman, “Protein interactions in human genetic diseases,” Genome Biology, vol. 9, no. 1, article R9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Navlakha and C. Kingsford, “The power of protein interaction networks for associating genes with diseases,” Bioinformatics, vol. 26, no. 8, pp. 1057–1063, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T.-P. Nguyen and T.-B. Ho, “Detecting disease genes based on semi-supervised learning and protein-protein interaction networks,” Artificial Intelligence in Medicine, vol. 54, no. 1, pp. 63–71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T.-P. Nguyen, W.-C. Liu, and F. Jordán, “Inferring pleiotropy by network analysis: linked diseases in the human PPI network,” BMC Systems Biology, vol. 5, article 179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Krauthammer, C. A. Kaufmann, T. C. Gilliam, and A. Rzhetsky, “Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's desease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 42, pp. 15148–15153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. Z.-P. Liu, Y. Wang, X.-S. Zhang, and L. Chen, “Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains,” BMC Systems Biology, vol. 4, no. 2, article 11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Goñi, F. J. Esteban, N. V. de Mendizábal et al., “A computational analysis of protein-protein interaction networks in neurodegenerative diseases,” BMC Systems Biology, vol. 2, article 52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Chen and R. D. Burgoyne, “Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms,” BMC Genomics, vol. 13, no. 1, article 71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Limviphuvadh, S. Tanaka, S. Goto, K. Ueda, and M. Kanehisa, “The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs),” Bioinformatics, vol. 23, no. 16, pp. 2129–2138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Vasaikar, A. Padhi, B. Jayaram, and J. Gomes, “NeuroDNet—an open source platform for constructing and analyzing neurodegenerative disease networks,” BMC Neuroscience, vol. 3, article 14, 2013. View at Google Scholar
  16. M. A. van Driel, J. Bruggeman, G. Vriend, H. G. Brunner, and J. A. M. Leunissen, “A text-mining analysis of the human phenome,” European Journal of Human Genetics, vol. 14, no. 5, pp. 535–542, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Hamosh, A. F. Scott, J. S. Amberger, C. A. Bocchini, and V. A. McKusick, “Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders,” Nucleic Acids Research, vol. 33, pp. D514–D517, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. “The medical subject headings vocabulary (MESH),” http://www.nlm.nih.gov/mesh/.
  19. K. R. Brown and I. Jurisica, “Online predicted human interaction database,” Bioinformatics, vol. 21, no. 9, pp. 2076–2082, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Bairoch, R. Apweiler, C. H. Wu et al., “The Universal Protein Resource (UniProt),” Nucleic Acids Research, vol. 33, pp. D154–D159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Zhang, G. Jin, X.-S. Zhang, and L. Chen, “Discovering functions and revealing mechanisms at molecular level from biological networks,” Proteomics, vol. 7, no. 16, pp. 2856–2869, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-H. Yook, Z. N. Oltvai, and A.-L. Barabási, “Functional and topological characterization of protein interaction networks,” Proteomics, vol. 4, no. 4, pp. 928–942, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Yu, P. M. Kim, E. Sprecher, V. Trifonov, and M. Gerstein, “The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics,” PLoS Computational Biology, vol. 3, no. 4, article e59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Zotenko, J. Mestre, D. P. O'Leary, and T. M. Przytycka, “Why do hubs in the yeast protein interaction network tend to be essential: reexamining the connection between the network topology and essentiality,” PLoS Computational Biology, vol. 4, no. 8, Article ID e1000140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Wasserman and S. Faust, Social Network Analysis, Cambridge University Press, Cambridge , UK, 1994.
  26. F. Jordán, W.-C. Liu, and A. J. Davis, “Topological keystone species: measures of positional importance in food webs,” Oikos, vol. 112, no. 3, pp. 535–546, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T. H. Cormen, C. E. Leiserson, R. L. Rivest, and C. Stein, Introduction to Algorithms, McGraw-Hill Science/Engineering/Math, 2nd edition, 2001.
  28. D. E. Knuth, Art of Computer Programming—volume 1: Fundamental Algorithms, Addison-Wesley Professional, 3rd edition, 1997.
  29. “COSBILab-Graph,” http://www.cosbi.eu/index.php/research/prototypes/graph.
  30. “Centralities in Biological Networks,” http://centibin.ipk-gatersleben.de/.
  31. Python, http://www.python.org/.
  32. “Network Analysis, Visualization, & Graphing TORonto,” http://ophid.utoronto.ca/navigator/.
  33. G. Bindea, B. Mlecnik, H. Hackl et al., “ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks,” Bioinformatics, vol. 25, no. 8, pp. 1091–1093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: a practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society B, vol. 57, no. 1, pp. 289–300, 1995. View at Google Scholar
  35. Z. Dong, A. Brennan, N. Liu et al., “Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors,” Neuron, vol. 15, no. 3, pp. 585–596, 1995. View at Google Scholar · View at Scopus
  36. B. Margolis, “Proteins with SH2 domains: transducers in the tyrosine kinase signaling pathway,” Cell Growth & Differentiation, vol. 3, no. 1, pp. 73–80, 1992. View at Google Scholar · View at Scopus
  37. I. Stancovski, E. Peles, R. B. Levy et al., “Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy,” Journal of Steroid Biochemistry and Molecular Biology, vol. 43, no. 1–3, pp. 95–103, 1992. View at Google Scholar · View at Scopus
  38. J. Bao, “Signal transduction by the cytoplasmic domain of NEUREGULIN-1 and its roles during neuronal aging,” Current Signal Transduction Therapy, vol. 2, no. 3, pp. 240–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Caceres and K. S. Kosik, “Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons,” Nature, vol. 343, no. 6257, pp. 461–463, 1990. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Schraen-Maschke, C.-M. Dhaenens, A. Delacourte, and B. Sablonnière, “Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases,” Neurobiology of Disease, vol. 15, no. 3, pp. 449–460, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Cruts, “Alzheimer Disease & Frontotemporal Dementia Mutation Database,” http://www.molgen.ua.ac.be/FTDmutations/.
  42. K.-I. Goh, M. E. Cusick, D. Valle, B. Childs, M. Vidal, and A.-L. Barabási, “The human disease network,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 21, pp. 8685–8690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. K. Wszolek, Y. Tsuboi, B. Ghetti, S. Pickering-Brown, Y. Baba, and W. P. Cheshire, “Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17),” Orphanet Journal of Rare Diseases, vol. 1, no. 1, article 30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. I. R. A. Mackenzie, “The neuropathology of FTD associated with ALS,” Alzheimer Disease and Associated Disorders, vol. 21, no. 4, pp. S44–S49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Goedert, “Alpha-synuclein and neurodegenerative diseases,” Nature Reviews Neuroscience, vol. 2, no. 7, pp. 492–501, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. C. L. Haigh, S. Y. Marom, and S. J. Collins, “Copper, endoproteolytic processing of the prion protein and cell signalling,” Frontiers in Bioscience, vol. 15, no. 3, pp. 1086–1104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. J. A. Mastrianni, “The genetics of prion diseases,” Genetics in Medicine, vol. 12, no. 4, pp. 187–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. C. W. Olanow and S. B. Prusiner, “Is Parkinson's disease a prion disorder?” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 31, pp. 12571–12572, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Dennis Jr., B. T. Sherman, D. A. Hosack et al., “DAVID: database for annotation, visualization, and integrated discovery,” Genome Biology, vol. 4, no. 5, article P3, 2003. View at Google Scholar · View at Scopus
  50. C. Y. Chung, J. B. Koprich, H. Siddiqi, and O. Isacson, “Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV α-synucleinopathy,” Journal of Neuroscience, vol. 29, no. 11, pp. 3365–3373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Okun, K. J. Griffioen, J. D. Lathia, S.-C. Tang, M. P. Mattson, and T. V. Arumugam, “Toll-like receptors in neurodegeneration,” Brain Research Reviews, vol. 59, no. 2, pp. 278–292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Frenkel, D. Trudler, and D. Farfara, “Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application,” Mediators of Inflammation, vol. 2010, Article ID 497987, 12 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Letiembre, Y. Liu, S. Walter et al., “Screening of innate immune receptors in neurodegenerative diseases: a similar pattern,” Neurobiology of Aging, vol. 30, no. 5, pp. 759–768, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Zucchelli, F. Marcuzzi, M. Codrich et al., “Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with Huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation,” Journal of Biological Chemistry, vol. 286, no. 28, pp. 25108–25117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Zucchelli, M. Codrich, F. Marcuzzi et al., “TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains,” Human Molecular Genetics, vol. 19, no. 19, pp. 3759–3770, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. L.-L. Wang, Y. Huang, G. Wang, and S.-D. Chen, “The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target?” Medical Hypotheses, vol. 78, no. 3, pp. 398–401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. X.-L. Pan, R.-J. Ren, G. Wang, H.-D. Tang, and S.-D. Chen, “The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer's disease,” Neuroscience Bulletin, vol. 26, no. 3, pp. 241–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. A. M. Tari and G. Lopez-Berestein, “GRB2: a pivotal protein in signal transduction,” Seminars in Oncology, vol. 28, no. 5, supplement 16, pp. 142–147, 2001. View at Google Scholar · View at Scopus
  59. J. Ashkenas and Z. Werb, “Proteolysis and the biochemistry of life-or-death decisions,” Journal of Experimental Medicine, vol. 183, no. 5, pp. 1947–1951, 1996. View at Publisher · View at Google Scholar · View at Scopus
  60. K. P. Wilson, J.-A. F. Black, J. A. Thomson et al., “Structure and mechanism of interleukin-1β converting enzyme,” Nature, vol. 370, no. 6487, pp. 270–275, 1994. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Yamada, K. Kida, W. Amutuhaire, F. Ichinose, and M. Kaneki, “Gene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice,” Biochemical and Biophysical Research Communications, vol. 402, no. 2, pp. 312–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Hartmann, J.-D. Troadec, S. Hunot et al., “Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis,” Journal of Neuroscience, vol. 21, no. 7, pp. 2247–2255, 2001. View at Google Scholar · View at Scopus
  63. J. H. Su, K. E. Nichol, T. Sitch et al., “DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia,” Experimental Neurology, vol. 163, no. 1, pp. 9–19, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Fiore, G. N. Chaldakov, and L. Aloe, “Nerve growth factor as a signaling molecule for nerve cells and also for the neuroendocrine-immune systems,” Reviews in the Neurosciences, vol. 20, no. 2, pp. 133–145, 2009. View at Google Scholar · View at Scopus
  65. M. A. Olayioye, “Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members,” Breast Cancer Research, vol. 3, no. 6, pp. 385–389, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. G. Chen, K. A. Bower, C. Ma, S. Fang, C. J. Thiele, and J. Luo, “Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine- induced neuronal death,” FASEB Journal, vol. 18, no. 10, pp. 1162–1164, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. O. Kaidanovich-Beilin and J. R. Woodgett, “GSK-3: functional insights from cell biology and animal models,” Frontiers in Molecular Neuroscience, vol. 4, article 40, 2011. View at Google Scholar
  68. W. Wang, Y. Yang, C. Ying et al., “Inhibition of glycogen synthase kinase-3β protects dopaminergic neurons from MPTP toxicity,” Neuropharmacology, vol. 52, no. 8, pp. 1678–1684, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Avila, F. Wandosell, and F. Hernández, “Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors,” Expert Review of Neurotherapeutics, vol. 10, no. 5, pp. 703–710, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. J. H. Hu, K. Chernoff, S. Pelech, and C. Krieger, “Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over-expressing mice,” Journal of Neurochemistry, vol. 85, no. 2, pp. 422–431, 2003. View at Google Scholar · View at Scopus
  71. S.-H. Koh, Y.-B. Lee, K. S. Kim et al., “Role of GSK-3β activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene,” European Journal of Neuroscience, vol. 22, no. 2, pp. 301–309, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Duka, V. Duka, J. N. Joyce, and A. Sidhu, “α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models,” FASEB Journal, vol. 23, no. 9, pp. 2820–2830, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. H.-L. Feng, Y. Leng, C.-H. Ma, J. Zhang, M. Ren, and D.-M. Chuang, “Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model,” Neuroscience, vol. 155, no. 3, pp. 567–572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. Y.-H. Kim, A. Rane, S. Lussier, and J. K. Andersen, “Lithium protects against oxidative stress-mediated cell death in α-synuclein-overexpressing in vitro and in vivo models of Parkinson's disease,” Journal of Neuroscience Research, vol. 89, no. 10, pp. 1666–1675, 2011. View at Publisher · View at Google Scholar · View at Scopus